000			01930 a2200589 4500
005			20250518094018.0
264		0	_c20200731
008			202007s 0 0 eng d
022			_a2041-1723
024	7		_a10.1038/s41467-020-15436-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aJanelidze, Shorena
245	0	0	_aCerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease. _h[electronic resource]
260			_bNature communications _c04 2020
300			_a1683 p. _bdigital
500			_aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlzheimer Disease _xcerebrospinal fluid
650	0	4	_aBiomarkers _xcerebrospinal fluid
650	0	4	_aBrain _xdiagnostic imaging
650	0	4	_aCarbolines _xadministration & dosage
650	0	4	_aContrast Media _xadministration & dosage
650	0	4	_aDiagnosis, Differential
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhosphorylation
650	0	4	_aPositron-Emission Tomography
650	0	4	_aSweden
650	0	4	_atau Proteins _xcerebrospinal fluid
700	1		_aStomrud, Erik
700	1		_aSmith, Ruben
700	1		_aPalmqvist, Sebastian
700	1		_aMattsson, Niklas
700	1		_aAirey, David C
700	1		_aProctor, Nicholas K
700	1		_aChai, Xiyun
700	1		_aShcherbinin, Sergey
700	1		_aSims, John R
700	1		_aTriana-Baltzer, Gallen
700	1		_aTheunis, Clara
700	1		_aSlemmon, Randy
700	1		_aMercken, Marc
700	1		_aKolb, Hartmuth
700	1		_aDage, Jeffrey L
700	1		_aHansson, Oskar
773	0		_tNature communications _gvol. 11 _gno. 1 _gp. 1683
856	4	0	_uhttps://doi.org/10.1038/s41467-020-15436-0 _zAvailable from publisher's website
999			_c30813598 _d30813598